Tumor Lysis Syndrome is a pattern of metabolic abnormalities that results from rapid cell breakdown. Proactive clinical intervention includes the prompt identification of patients at risk, the implementation of appropriate medications as well as scrupulous fluid and electrolyte assessment and management.
